Viking Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. 

CEO
Brian Lian
CEOBrian Lian
Employees
53
Employees53
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2012
Founded2012
Employees
53
Employees53

VKTX Key Statistics

Market cap
3.48B
Market cap3.48B
Price-Earnings ratio
-5.87
Price-Earnings ratio-5.87
Dividend yield
—
Dividend yield—
Average volume
5.84M
Average volume5.84M
High today
$27.61
High today$27.61
Low today
$25.64
Low today$25.64
Open price
$26.00
Open price$26.00
Volume
5.23M
Volume5.23M
52 Week high
$43.15
52 Week high$43.15
52 Week low
$25.28
52 Week low$25.28

Stock Snapshot

Viking Therapeutics(VKTX) stock is priced at $27.46, giving the company a market capitalization of 3.48B. It carries a P/E multiple of -5.87.

As of 2026-10-15, Viking Therapeutics(VKTX) stock has fluctuated between $25.64 and $27.61. The current price stands at $27.46, placing the stock +7.1% above today's low and -0.5% off the high.

The Viking Therapeutics(VKTX)'s current trading volume is 5.23M, compared to an average daily volume of 5.84M.

In the last year, Viking Therapeutics(VKTX) shares hit a 52-week high of $43.15 and a 52-week low of $25.28.

In the last year, Viking Therapeutics(VKTX) shares hit a 52-week high of $43.15 and a 52-week low of $25.28.

VKTX News

Zacks 2d
Wall Street Bulls Look Optimistic About Viking Therapeutics: Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating...

Wall Street Bulls Look Optimistic About Viking Therapeutics: Should You Buy?
Simply Wall St 6d
VK2735 Maintenance Study Could Be A Big Test For Viking Therapeutics Stock - Simply Wall Street

...

VK2735 Maintenance Study Could Be A Big Test For Viking Therapeutics Stock - Simply Wall Street
Zacks 6d
Viking Therapeutics, Inc. Exceeds Market Returns: Some Facts to Consider

In the latest trading session, Viking Therapeutics, Inc. (VKTX Quick QuoteVKTX - Free Report) closed at $28.53, marking a +2.88% move from the previous da...

Viking Therapeutics, Inc. Exceeds Market Returns: Some Facts to Consider

Analyst ratings

90%

of 21 ratings
Buy
90.5%
Hold
9.5%
Sell
0%

People also own

Based on the portfolios of people who own VKTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.